392 related articles for article (PubMed ID: 7884845)
1. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses.
Yang Y; Li Q; Ertl HC; Wilson JM
J Virol; 1995 Apr; 69(4):2004-15. PubMed ID: 7884845
[TBL] [Abstract][Full Text] [Related]
2. Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs.
Yang Y; Su Q; Wilson JM
J Virol; 1996 Oct; 70(10):7209-12. PubMed ID: 8794368
[TBL] [Abstract][Full Text] [Related]
3. Immune-mediated loss of transgene expression in skin: implications for cutaneous gene therapy.
Ghazizadeh S; Kalish RS; Taichman LB
Mol Ther; 2003 Mar; 7(3):296-303. PubMed ID: 12668125
[TBL] [Abstract][Full Text] [Related]
4. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses.
Yang Y; Ertl HC; Wilson JM
Immunity; 1994 Aug; 1(5):433-42. PubMed ID: 7533647
[TBL] [Abstract][Full Text] [Related]
5. "Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung.
Croyle MA; Chirmule N; Zhang Y; Wilson JM
J Virol; 2001 May; 75(10):4792-801. PubMed ID: 11312351
[TBL] [Abstract][Full Text] [Related]
6. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung.
Yang Y; Trinchieri G; Wilson JM
Nat Med; 1995 Sep; 1(9):890-3. PubMed ID: 7585213
[TBL] [Abstract][Full Text] [Related]
7. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo.
Yang Y; Jooss KU; Su Q; Ertl HC; Wilson JM
Gene Ther; 1996 Feb; 3(2):137-44. PubMed ID: 8867861
[TBL] [Abstract][Full Text] [Related]
8. Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a.
Engelhardt JF; Litzky L; Wilson JM
Hum Gene Ther; 1994 Oct; 5(10):1217-29. PubMed ID: 7849095
[TBL] [Abstract][Full Text] [Related]
9. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector.
Juillard V; Villefroy P; Godfrin D; Pavirani A; Venet A; Guillet JG
Eur J Immunol; 1995 Dec; 25(12):3467-73. PubMed ID: 8566039
[TBL] [Abstract][Full Text] [Related]
10. Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor.
Mahon BP; Katrak K; Nomoto A; Macadam AJ; Minor PD; Mills KH
J Exp Med; 1995 Apr; 181(4):1285-92. PubMed ID: 7699320
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo.
Yang Y; Xiang Z; Ertl HC; Wilson JM
Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7257-61. PubMed ID: 7638177
[TBL] [Abstract][Full Text] [Related]
12. Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig.
Jooss K; Turka LA; Wilson JM
Gene Ther; 1998 Mar; 5(3):309-19. PubMed ID: 9614550
[TBL] [Abstract][Full Text] [Related]
13. Effect of Pseudomonas-induced chronic lung inflammation on specific cytotoxic T-cell responses to adenoviral vectors in mice.
Tosi MF; van Heeckeren A; Ferkol TW; Askew D; Harding CV; Kaplan JM
Gene Ther; 2004 Oct; 11(19):1427-33. PubMed ID: 15295614
[TBL] [Abstract][Full Text] [Related]
14. Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IX.
Fields PA; Kowalczyk DW; Arruda VR; Armstrong E; McCleland ML; Hagstrom JN; Pasi KJ; Ertl HC; Herzog RW; High KA
Mol Ther; 2000 Mar; 1(3):225-35. PubMed ID: 10933938
[TBL] [Abstract][Full Text] [Related]
15. Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues.
Yang Y; Su Q; Grewal IS; Schilz R; Flavell RA; Wilson JM
J Virol; 1996 Sep; 70(9):6370-7. PubMed ID: 8709265
[TBL] [Abstract][Full Text] [Related]
16. Transient immune blockade prevents formation of neutralizing antibody to recombinant adenovirus and allows repeated gene transfer to mouse liver.
Yang Y; Greenough K; Wilson JM
Gene Ther; 1996 May; 3(5):412-20. PubMed ID: 9156802
[TBL] [Abstract][Full Text] [Related]
17. Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis.
Fisher KJ; Choi H; Burda J; Chen SJ; Wilson JM
Virology; 1996 Mar; 217(1):11-22. PubMed ID: 8599194
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis.
Yang Y; Nunes FA; Berencsi K; Gönczöl E; Engelhardt JF; Wilson JM
Nat Genet; 1994 Jul; 7(3):362-9. PubMed ID: 7522742
[TBL] [Abstract][Full Text] [Related]
19. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.
Yang Y; Nunes FA; Berencsi K; Furth EE; Gönczöl E; Wilson JM
Proc Natl Acad Sci U S A; 1994 May; 91(10):4407-11. PubMed ID: 8183921
[TBL] [Abstract][Full Text] [Related]
20. Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype.
Sparer TE; Wynn SG; Clark DJ; Kaplan JM; Cardoza LM; Wadsworth SC; Smith AE; Gooding LR
J Virol; 1997 Mar; 71(3):2277-84. PubMed ID: 9032363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]